Pliant Therapeutics, Inc. (PLRX)
NASDAQ·Healthcare·Biotechnology
$1.13
-0.88%
Mkt Cap $65.64M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+165.5%
Consensus $3.00 vs current $1.13
NASDAQ·Healthcare·Biotechnology
$1.13
-0.88%
Mkt Cap $65.64M
No recent rating data.
Price Target (11 analysts)
$3.00
Range $3.00 – $3.00
+165.5%
Consensus $3.00 vs current $1.13